Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Hutchison China MediTech Limited    HCM   KYG4672N1198

HUTCHISON CHINA MEDITECH LIMITED

(HCM)
  Report
SummaryQuotesNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Sales 216 241 214 197 215 286
EBITDA -44,4 -53,5 -89,1 -138 -167 -108
Operating profit (EBIT) -46,7 -56,1 -92,6 -143 -171 -122
Pre-Tax Profit (EBT) -47,4 -53,5 -86,7 -152 -188 -153
Net income 11,7 -26,7 -74,8 -121 -151 -123
P/E ratio - - - -24,9x -19,3x -24,1x
EPS ( $ ) 0,02 -0,04 -0,11 -0,18 -0,23 -0,19
Dividend per Share ( $ ) - - - - - -
Yield - - - - - -
Reference price ( $ ) - - - 4,513 4,513 4,513
Announcement Date 03/13/2017
07:00am
03/12/2018
07:02am
03/11/2019
02:00am
- - -
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Debt - - - - - -
Finance 56,9 55,3 274 165 98,3 20,5
Operating income (EBITDA) -44,4 -53,5 -89,1 -138 -167 -108
Leverage
(Debt/EBITDA)
- - - - - -
Capital Expenditure 4,33 5,02 6,36 10,1 10,8 6,36
Free Cash Flow (FCF) -13,9 -14,0 -39,2 -141 -156 -136
Book Value Per Share (BVPS) (  ) - - - 0,40 0,67 0,48
Cash Flow per Share ( $ ) -0,02 -0,01 -0,05 -0,13 -0,11 -0,19
Announcement Date 03/13/2017
07:00am
03/12/2018
07:02am
03/11/2019
02:00am
- - -
Balance Sheet Analysis
Assessed data source
© 2020 S&P Global Market Intelligence
Financial Ratios

Size 2019e 2020e
Capitalization 3 105 M $ -
Entreprise Value (EV) 2 940 M $ 3 007 M $
Valuation 2019e 2020e
P/E ratio (Price / EPS) -24,9x -19,3x
Capitalization / Revenue 15,7x 14,4x
EV / Revenue 14,9x 13,7x
EV / EBITDA -21,3x -17,6x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 11,4x 6,69x
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) -72,3% -79,3%
Operating Leverage (Delta EBIT / Delta Sales) -6,95x -
Net Margin (Net Profit / Revenue) -61,2% -70,0%
ROA (Net Profit / Asset) -26,9% -38,6%
ROE (Net Profit / Equities) -36,6% -61,1%
Rate of Dividend - -
Balance Sheet Analysis 2019e 2020e
CAPEX / Sales   5,12% 5,03%
Cash Flow / Sales -45,9% -35,1%
Capital Intensity (Assets / Sales) 2,27x 1,82x
Financial Leverage (Net Debt / EBITDA) - -
EPS & Dividend